|
|
||||||||
Mayo Clinic and Mayo Foundation, Rochester, MN.
The incidence, trend, and survivorship of ALS in the population of Rochester, Minnesota, was determined for the years 1925 through 1977. The average annual incidence was 1.76 per 100,000 population. There was a small but nonsignificant increase in the rate during the 53-year period. The male:female ratio was 1.1, and the male:female ratio of incidence rates was 1.6. The median age at onset was 66 years; the incidence rates increased with increasing age. Median survivorship was 22.5 months, and was longer for younger patients than for patients with an advanced age at onset. The demographic characteristics in this total community experience are believed to reflect the pattern of ALS more accurately than previously reported clinical series.
Address correspondence and reprint requests to Dr. Kurland, Mayo Clinic, 200 First Street SW, Rochester, MN 55901
This investigation was supported in part by Research Grant No. GM-14231 from the National Institutes of Health, Public Health Service, and from the St. Gerard Foundation.
Accepted for publication September 4, 1979.
This article has been cited by other articles:
![]() |
G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Simmons, S. H. Felgoise, B. A. Bremer, S. M. Walsh, D. J. Hufford, M. B. Bromberg, W. David, D. A. Forshew, T. D. Heiman-Patterson, E. C. Lai, et al. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology, November 14, 2006; 67(9): 1659 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Noonan, M. C. White, D. Thurman, and L.-Y. Wong Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998 Neurology, April 12, 2005; 64(7): 1215 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chio, R. Mutani, G. Mora, W.T. Longstreth Jr., and M.A. del Aguila Prognosis in amyotrophic lateral sclerosis: A population-based study Neurology, December 23, 2003; 61(12): 1826 - 1827. [Full Text] [PDF] |
||||
![]() |
R. W. Haley Excess incidence of ALS in young Gulf War veterans Neurology, September 23, 2003; 61(6): 750 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.A. del Aguila, W.T. Longstreth Jr, V. McGuire, T.D. Koepsell, and G. van Belle Prognosis in amyotrophic lateral sclerosis: A population-based study Neurology, March 11, 2003; 60(5): 813 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mandrioli, P. Faglioni, E. Merelli, and P. Sola The epidemiology of ALS in Modena, Italy Neurology, February 25, 2003; 60(4): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Sorenson, A. P. Stalker, L. T. Kurland, and A. J. Windebank Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998 Neurology, July 23, 2002; 59(2): 280 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Payne and A. D. Roses The Molecular Genetic Revolution: Its Impact on Clinical Neurology Arch Neurol, December 1, 1988; 45(12): 1366 - 1376. [Abstract] [PDF] |
||||
![]() |
H. Mitsumoto, M. R. Hanson, and D. A. Chad Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials Arch Neurol, February 1, 1988; 45(2): 189 - 202. [Abstract] [PDF] |
||||
![]() |
J. E. Riggs Trauma and Amyotrophic Lateral Sclerosis Arch Neurol, March 1, 1985; 42(3): 205 - 205. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |